BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9623285)

  • 21. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
    Griffiths UK; Hutton G; Das Dores Pascoal E
    Health Policy Plan; 2005 Jan; 20(1):50-9. PubMed ID: 15689430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
    Kim SY; Billah K; Lieu TA; Weinstein MC
    Am J Prev Med; 2006 Jun; 30(6):498-506. PubMed ID: 16704944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy of hepatitis B vaccination on hepatitis B prevention and on hepatocellular carcinoma].
    Li RC; Yang JY; Gong J; Li YP; Huang ZN; Fang KX; Xu ZY; Liu CB; Zhao K; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):385-7. PubMed ID: 15231157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness.
    Vimolket T; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):693-9. PubMed ID: 16124440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The global impact of vaccination against hepatitis B: a historical overview.
    Zanetti AR; Van Damme P; Shouval D
    Vaccine; 2008 Nov; 26(49):6266-73. PubMed ID: 18848855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis A: disease burden and current childhood vaccination strategies in the United States.
    Koslap-Petraco MB; Shub M; Judelsohn R
    J Pediatr Health Care; 2008; 22(1):3-11. PubMed ID: 18174084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates.
    Jacobs RJ; Rosenthal P; Meyerhoff AS
    Vaccine; 2004 Mar; 22(9-10):1241-8. PubMed ID: 15003653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experience with the new German hepatitis B vaccination strategy since 1995.
    Krämer A; Prüfer-Krämer L
    Int J STD AIDS; 2002 Dec; 13 Suppl 2():35-7. PubMed ID: 12537724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hepatitis vaccination of adults].
    Jost R
    Schweiz Med Wochenschr; 1998 Jul; 128(27-28):1104-9. PubMed ID: 9691345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of acute hepatitis B--United States, 1990-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Jan; 52(51-52):1252-4. PubMed ID: 14704650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A study on the coverage, strategy and cost of hepatitis B vaccination in China, 1996].
    Zeng X; Yang G; Liao S
    Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Oct; 19(5):277-81. PubMed ID: 10322686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The impact of hepatitis B vaccination in Italy and the advent of novel recombinant vaccines containing pre-S1 and pre-S2].
    Romanò L; Biffi R; Bianchi S; Zanetti A
    Ann Ig; 2002; 14(3 Suppl 3):19-25. PubMed ID: 12389407
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatitis B vaccination in countries with low endemicity.
    Prescrire Int; 2000 Feb; 9(45):213-9. PubMed ID: 11503803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The risk of acquiring hepatitis A and B among travelers in selected Eastern and Southern Europe and non-European Mediterranean countries: review and consensus statement on hepatitis A and B vaccination.
    Nothdurft HD; Dahlgren AL; Gallagher EA; Kollaritsch H; Overbosch D; Rummukainen ML; Rendi-Wagner P; Steffen R; Van Damme P;
    J Travel Med; 2007; 14(3):181-7. PubMed ID: 17437475
    [No Abstract]   [Full Text] [Related]  

  • 35. [Mobilize parents to vaccinate their children against hepatitis B: the role of the pediatrician].
    Gaudelus J
    Arch Pediatr; 2010 Mar; 17(3 Suppl):6-13. PubMed ID: 20304345
    [No Abstract]   [Full Text] [Related]  

  • 36. [Vaccination against Hepatitis B Virus in chronic renal disease patients].
    Franco E; Senatore S; Ruggiero F; Papa R; Zaratti L
    Ig Sanita Pubbl; 2008 Jan; 64(1):131-6. PubMed ID: 18379610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benefits of early hepatitis B immunization programs for newborns and infants.
    Van Herck K; Van Damme P
    Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-HBs profiles in children treated for neoplastic disease who had been vaccinated against hepatitis B postnatally or as infants.
    Koltan S; Koltan A; Wysocki M; Debski R; Styczynski J
    J Hosp Infect; 2005 May; 60(1):73-7. PubMed ID: 15823661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies.
    Ni YH; Huang LM; Chang MH; Yen CJ; Lu CY; You SL; Kao JH; Lin YC; Chen HL; Hsu HY; Chen DS
    Gastroenterology; 2007 Apr; 132(4):1287-93. PubMed ID: 17433322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.